일시 : 2019년 10월 12일 (토)
장소 : 한양대학교 HIT 빌딩6층 대강당
연수평점 : 3점
사회 : 박동원(한양의대)
Time | Title | Speaker & Chairperson |
---|---|---|
12:20 ~ 12:55 | Registration | |
12:55 ~ 13:00 | Opening address | 이민기 (표적치료연구회장) |
Section 1: Targeting MET pathways in lung cancer treatment |
좌장: 이민기 (부산의대), 장세진 (울산의대) |
|
13:00 ~ 13:20 | Molecular diagnostics of MET alterations in lung cancer | 심효섭 (연세의대) |
13:20 ~ 13:40 | MET exon 14 mutations in lung adenocarcinomas | 이상훈 (연세의대) |
13:40 ~ 14:00 | MET pathways as a resistant mechanism of target agents | 남해성 (인하의대) |
14:00 ~ 14:10 | Q & A | |
14:10 ~ 14:30 | Coffee Break | |
Section 2: Targeting angiogenesis in lung cancer treatment
|
좌장: 김영철 (전남의대), 이창훈 (부산의대) |
|
14:30 ~ 14:50 | Anti-angiogenic therapy: current status and future perspectives | 김태정 (가톨릭의대) |
14:50 ~ 15:10 | EGFR and anigogenesis, dual targets in EGFR mutant lung cancers | 박순효 (계명의대) |
15:10 ~ 15:30 | Lymphovascular invasion as a T descriptor, is it evident? | 신동훈 (부산의대) |
15:30 ~ 15:40 | Q & A | |
15:40 ~ 16:00 | Coffee Break | |
Section 3: Specific organ metastases and prognosis in lung cancer
|
좌장: 이계영 (건국의대), 류정선 (인하의대) |
|
16:00 ~ 16:20 | Liver metastasis: clinical evidence, mechanism and treatment | 김서윤 (원자력병원) |
16:20 ~ 16:40 | Bone metastasis: clinical evidence, mechanism and treatment | 홍윤기 (강원의대) |
16:40 ~ 17:00 | Leptomeningeal metastasis: clinical evidence, mechanism and treatment | 오인재 (전남의대) |
17:00 |
Closing |